John Conyers said...

These regulatory requirements are an important safeguard to ensure that drugs with potentially dangerous characteristics...

Clearly, this program works, and we must continue to support it.

Over-penalization would be counterproductive and only contribute to our crisis of over-incarceration.

We should of course remain vigilant about pay-for-delay schemes, whereby branded drug manufacturers pay generic manufact...